Clinical review: New technologies for prevention of intravascular catheter-related infections

被引:43
作者
Cicalini, S [1 ]
Palmieri, F [1 ]
Petrosillo, N [1 ]
机构
[1] IRCCS, Ist Nazl Malattie Infett Lazzaro Spallanzani, Infect Dis Unit 2, Rome, Italy
来源
CRITICAL CARE | 2004年 / 8卷 / 03期
关键词
catheter-related bloodstream infections; central venous catheters; new technologies; prevention;
D O I
10.1186/cc2380
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Intravascular catheters have become essential devices for the management of critically and chronically ill patients. However, their use is often associated with serious infectious complications, mostly catheter-related bloodstream infection (CRBSI), resulting in significant morbidity, increased duration of hospitalization, and additional medical costs. The majority of CRBSIs are associated with central venous catheters (CVCs), and the relative risk for CRBSI is significantly greater with CVCs than with peripheral venous catheters. However, most CVC-related infections are preventable, and different measures have been implemented to reduce the risk for CRBSI, including maximal barrier precautions during catheter insertion, catheter site maintenance, and hub handling. The focus of the present review is on new technologies for preventing infections that are directed at CVCs. New preventive strategies that have been shown to be effective in reducing risk for CRBSI, including the use of catheters and dressings impregnated with antiseptics or antibiotics, the use of new hub models, and the use of antibiotic lock solutions, are briefly described.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 55 条
[1]   Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters [J].
Bach, A ;
Schmidt, H ;
Bottiger, B ;
Schreiber, B ;
Bohrer, H ;
Motsch, J ;
Martin, E ;
Sonntag, HG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) :315-322
[2]  
BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
[3]   Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo [J].
Bassetti, S ;
Hu, J ;
D'Agostino, RB ;
Sherertz, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) :1535-1538
[4]  
BONAWITZ SC, 1991, AM SURGEON, V57, P618
[5]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[6]   Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer [J].
Chatzinikolaou, I ;
Zipf, TF ;
Hanna, H ;
Umphrey, J ;
Roberts, WM ;
Sherertz, R ;
Hachem, R ;
Raad, I .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :116-119
[7]   INTRAVASCULAR CATHETER-ASSOCIATED SEPSIS - A COMMON PROBLEM [J].
COLLIGNON, PJ .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (06) :374-378
[8]  
Cookson ST, 1998, INFECT CONT HOSP EP, V19, P28
[9]   The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices [J].
Crnich, CJ ;
Maki, DG .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1232-1242
[10]  
DAHLBERG PJ, 1995, INFECT CONT HOSP EP, V16, P506